News
Abraham Anghik Ruben is a world-renowned sculptor who's been creating groundbreaking and genre-defining work for the last ...
The modelling and simulation research team at the NRC's Automotive and Surface Transportation Research Centre is a leader in ...
Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance for Scemblix® (asciminib tablets ...
Complete Response Letters recently issued by the FDA signal heightened scrutiny of trial design and reinforce the agency’s shifting regulatory expectations for sponsors and CROs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results